婴幼儿感染性腹泻的联合治疗方法分析

目的探讨培菲康、思密达、山莨菪碱联合治疗婴幼儿感染性腹泻的临床疗效。方法选取三亚市人民医院2012年3月至2014年3月收治的小儿感染性腹泻患者120例,采用随机数字表法分为三组:A组40例,在常规方法的基础上采用培菲康治疗;B组40例,在常规方法的基础上采用培菲康、思密达联合治疗;C组40例,在常规方法的基础上采用培菲康、思密达、山莨菪碱联合治疗。记录各组患儿各项体征恢复时间,并依据治疗标准记录各组患儿的总有效率。结果 C组患儿止吐时间、止泻时间、体温恢复时间、脱水纠正时间、大便性状正常时间短于A组和B组,差异均有统计学意义(P<0.05)。C组婴幼儿感染性腹泻患儿治疗后的总有效率为97.5%,高于A组的75%和B组的92.5%,差异均有统计学意义(P<0.05)。结论培菲康、思密达、山莨菪碱联合使用对于治疗婴幼儿感染性腹泻的治疗进程具有明显的促进作用,疗效显著,值得临床推广。

The Analysis on Combined Treatment of Infectious Diarrhea in Infants

Objective To explore the clinical efficacy of Bifico Smecta anisodamine combination therapy on infectious diarrhea in infants.Methods A total of 120 pediatric patients with infectious diarrhea who were treated in Hainan Provincial People＇s Hospital from Mar.2012 to Mar.2014 were randomly divided into three groups accoding to random number table method：group A of 40 cases,given bifico treatment on the basis of conventional method.Group B of 40 cases,given bifico,smecta therapy on the basis of conventional method,group C of 40 cases,given bifico,smecta,anisodamine treatment.Body signs recovery time of different groups was recorded,and the total efficiency of each group was recorded according to the treatment standard.Results The antiemetic time,antidiarrheal time,temperature recovery time,dehydration corrected time and normal stool time of group C were shorter than groups A and B,with statistically significant difference （P 〈 0.05）.The total effective rate of infectious diarrhea in infants and young children of group C was 97.5%,higher than 75% of group A and 92.5 % of group B,with statistically significant difference（P 〈0.05）.Conclusion The combined application of bifico,smecta,and anisodamine can significantly help the treatment of infectious diarrhea in infants and children,thus is worthy of promotion in clinical.